DexCare Bags $20M in Oversubscribed Series A Round of Financing

DexCare, a Platform-as-a-Service (PaaS) that maintains health system capacity and demand across all lines of care, is intelligent digital care operating system.

FREMONT, CA: DexCare, a newly formed digital health company, has declared a $20M investment led by Define Ventures and including Frist Cressey Ventures, Kaiser Permanente Ventures, SpringRock Ventures and Providence Ventures.

DexCare, a Platform-as-a-Service (PaaS) that maintains health system capacity and demand across all lines of care, is intelligent digital care operating system. Community Health Network, the Froedtert and the Medical College of Wisconsin health network, Houston Methodist, and Providence are among its clients. DexCare was spun out as a separate company concurrent with the funding after being incubated at Providence's Digital Innovation Group.

Providence, one of the country's largest and most technologically advanced health systems, created DexCare. DexCare has been driving patient acquisition, navigation, and capacity optimization for Providence since 2016. It was originally created as a platform for the organization's ambulatory care industry.

"DexCare was instrumental as we transformed our ambulatory care model to better meet the needs of patients over the past few years. In 2020, scalability of the DexCare platform was instrumental in our response to COVID," said Rod Hochman, M.D., president and CEO, Providence. "We're proud that this internally developed and incubated technology is now ready to be made available to other health systems—furthering the Providence vision of health for a better world."